Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) EBIT: 2019-2024

Historic EBIT for MDxHealth (MDXH) over the last 6 years, with Dec 2024 value amounting to -$24.7 million.

  • MDxHealth's EBIT rose 20.55% to $26.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.5 million, marking a year-over-year increase of 14.06%. This contributed to the annual value of -$24.7 million for FY2024, which is 9.53% up from last year.
  • According to the latest figures from FY2024, MDxHealth's EBIT is -$24.7 million, which was up 9.53% from -$27.3 million recorded in FY2023.
  • MDxHealth's 5-year EBIT high stood at -$24.7 million for FY2024, and its period low was -$37.9 million during FY2022.
  • Its 3-year average for EBIT is -$30.0 million, with a median of -$27.3 million in 2023.
  • In the last 5 years, MDxHealth's EBIT surged by 37.17% in 2020 and then tumbled by 41.20% in 2022.
  • Over the past 5 years, MDxHealth's EBIT (MRY) stood at -$27.1 million in 2020, then rose by 1.04% to -$26.8 million in 2021, then tumbled by 41.20% to -$37.9 million in 2022, then grew by 27.90% to -$27.3 million in 2023, then rose by 9.53% to -$24.7 million in 2024.
  • Its last three reported values are -$24.7 million in FY2024, -$27.3 million for FY2023, and -$37.9 million during FY2022.